Tasigna and Cleocin t drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Tasigna and Cleocin t together.

The phase IV clinical study analyzes what interactions people who take Tasigna and Cleocin t have. It is created by eHealthMe based on reports of 3 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

3 people who take Tasigna and Cleocin t together, and have interactions are studied.


What is Tasigna?

Tasigna has active ingredients of nilotinib hydrochloride monohydrate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 28,631 Tasigna users for its effectiveness, alternative drugs and more.

What is Cleocin t?

Cleocin t has active ingredients of clindamycin phosphate. eHealthMe is studying from 544 Cleocin t users for its effectiveness, alternative drugs and more.

Number of Tasigna and Cleocin t reports submitted per year:

Tasigna and Cleocin t drug interactions.

Common Tasigna and Cleocin T drug interactions by gender *:

female:

n/a

male:

  1. Rash erythematous
  2. Chest pain

Common Tasigna and Cleocin T drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Rash erythematous
  2. Chest pain

* Approximation only. Some reports may have incomplete information.

Do you take Tasigna and Cleocin t?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Tasigna and Cleocin t:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tasigna side effects:

Browse all side effects of Tasigna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tasigna interactions:

Browse all interactions between Tasigna and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cleocin t interactions:

Browse all interactions between Cleocin t and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nilotinib hydrochloride monohydrate and clindamycin phosphate (the active ingredients of Tasigna and Cleocin t, respectively), and Tasigna and Cleocin t (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Tasigna and Cleocin t.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: